Document:

<PAGE>

                                  Exhibit 10(b)

                       SUBSCRIPTION AND PURCHASE AGREEMENT

                             UP TO 1,774,080 SHARES

                           OF SERIES C PREFERRED STOCK

         THIS SUBSCRIPTION AND PURCHASE AGREEMENT (the "Agreement") is entered
into as of the ____ day of _________, 1996 by and between OXIS INTERNATIONAL,
INC., a Delaware corporation (the "Company"), and [all investors identified in
attachment to this Subscription] (the "Investor").

         In consideration of the mutual promises, representations, warranties,
covenants and conditions set forth in this Agreement, the Company and the
Investor mutually agree as follows:

                                    ARTICLE l

                        Description of Proposed Financing

         1.1      Authorization of Sale of Series C Preferred. The Company has
                  -------------------------------------------
authorized the offer, issuance and sale (the "Offering") of a maximum of
1,774,080 shares of Series C Preferred Stock ("Series C Preferred"), pursuant to
the Overseas Memorandum (defined below) and the U.S. Memorandum (defined below).
The Company, upon its sole discretion, may increase the amount of Series C
Preferred sold in the Offering. The rights and preferences of the Series C
Preferred shall be as set forth in the Certificate of Designations, Preferences
and Rights of Series C Preferred Stock attached as Exhibit A hereto which has
been filed with the Delaware Secretary of State ("Certificate of Designations").

         1.2      Purchase and Sale of the Series C Preferred. Subject to the
                  -------------------------------------------
terms and conditions of this Agreement and in reliance upon the representations
and warranties contained herein, the Company agrees to sell to the Investor and
to other investors signing similar forms of Subscription and Purchase Agreement
the shares of Series C Preferred for which each such Investor shall subscribe.
The exact amount of the Investor's subscription is set forth in Section 8.1
hereof. The purchase price per share of Series C Preferred is U.S. $1.30.

         1.3      Closing. The Closing of the purchase and sale of the Series C
                  -------
Preferred contemplated by this Agreement (herein the "Closing") shall take place
at such time as agreed between the Company and the Investor. At the Closing, the
Company shall deliver to the Investor one or more Certificates evidencing the
shares of Series C Preferred to be purchased by such Investor, against delivery
to the Company by the Investor of a certified or cashier's check (or other form
of payment acceptable to the Company) in the amount of the purchase price of the
Series C Preferred.

                                    ARTICLE 2

                  Representations and Warranties of the Company

         The Company hereby represents and warrants to the Investors that:

         2.1      Disclosure. The Company has provided to the Investor the
                  ----------
Company's

                                       1

<PAGE>

Confidential Private Placement Memorandum, dated March 18, 1996 (the "U.S.
Memorandum") together with the Company's Confidential Private Placement
Memorandum, dated January 26, 1996 (the "Overseas Memorandum"), which includes
as exhibits, without limitation, the Company's Business Plan dated January 1996
and the Company's Annual Report on Form 10-K for the fiscal year ended December
31, 1994 and its quarterly reports on Form 10-Q for the quarterly periods ended
March 31, 1995, June 30, 1995 and September 30, 1995, in addition to certain
Risk Factors disclosure (collectively, the "Offering Documents"). The Company
has fully provided the Investor with all the information which the Investor has
requested for deciding whether to purchase the Series C Preferred. The Investor
acknowledges that the Company is engaged in an offering of the Series C
Preferred solely to investors outside the United States (as described in the
Overseas Memorandum, hereinafter referred to the "Overseas Offering") and
acknowledges and agrees that this Offering is a simultaneous offering solely to
U.S. investors pursuant to Regulation D promulgated pursuant to the Securities
Act of 1933, as amended.

         2.2      Binding Obligation. This Agreement and each additional
                  ------------------
agreement expressly contemplated by this Agreement, constitute a valid and
legally binding obligation of the Company.

                                    ARTICLE 3

                 Representations and Warranties of the Investor

         3.1      High Risk Investment. The Investor is aware that investment in
                  --------------------
the Series C Preferred involves a high degree of risk. The Investor represents
that it has read and carefully considered the disclosures set forth in this
Agreement and the Offering Documents, including the risk factors enumerated
herein and in the Offering Documents, and it understands that an investment in
this Offering should be considered only by a person able to withstand a total
loss of its investment.

         3 .2     Binding Obligations. This Agreement and each additional
                  -------------------
agreement expressly contemplated by this Agreement, constitutes a valid and
legally binding obligation of the Investor.

         3. 3     Corporate Investors. If the Investor is a corporation, it
                  -------------------
hereby represents and warrants that:

                  (a)      Organization and Standing. The Investor is a
corporation duly organized, validly existing, and in good standing under the
laws of its jurisdiction of incorporation, and has all requisite corporate power
and authority to own its properties and to carry on its business as now
conducted.

                  (b)      Authorization. All corporate action on the part of
                           -------------
the Investor, its officers and directors necessary for the authorization,
execution and delivery of this Agreement and all additional agreements expressly
contemplated by this Agreement and the performance of all obligations of the
Investor hereunder have been taken or will be taken prior to the Closing.

                                    ARTICLE 4

                        Federal and Other Securities Laws

         4.1      Investment Representations and Warranties. As an inducement to
                  -----------------------------------------
the Company to sell Series C Preferred to the Investor, the Investor hereby
agrees, represents and warrants, as of the date of acceptance of the Investor's
subscription:

                  (a)      By reason of the Investor's knowledge and experience
in financial and business matters in general, and investments in particular, the
Investor is able to evaluate the merits and risks of an investment in the
Securities. For purposes of this Article 4, the term "Securities" shall mean
each of the shares of

                                       2

<PAGE>

Series C Preferred and the shares of Company Common Stock (the "Common Stock")
into which shares of Series C Preferred may be converted.

                  (b)      The Investor's income and net worth are such that the
Investor is not now required, and does not contemplate in the future being
required, to dispose of any portion of any investment in the Securities to
satisfy any existing or contemplated undertaking.

                  (c)      In evaluating the merits and risks of an investment
in the Securities, the Investor has relied solely upon the Offering Documents
and the advice of its legal counsel, tax advisors, and/or investment advisors.

                  (d)      The Investor is able to bear the economic risk of an
investment in the Securities, including without limiting the generality of the
foregoing, the risk of losing part or all of the Investor's investment in the
Securities, and the inability to sell or transfer the Securities for an
indefinite period of time or at a price which would enable the Investor to
recoup its investment in the Securities.

                  (e)      The Investor's purchase of the Securities is as
principal, solely for the Investor's own account, for investment, and not with
an intent to sell, or for sale in connection with any distribution of the
Securities, and no other person has any interest in or right with respect to the
Securities, nor has the Investor agreed to give any person any such interest or
right in the future.

                  (f)      The Investor is an "accredited investor" as that term
is defined in Section 501(a) of Regulation D of the Securities Act of 1933, as
amended (the "Securities Act"). An "accredited investor" includes, among other
persons and entities. (1) a natural person whose net worth, or joint net worth
with that person's spouse, exceeds $1,000,000; (2) a natural person who has had
income in excess of $200,000 in each of the two most recent years, or, with that
person's spouse, in excess of $300,000 in those years, and who expects to have
at least that level of income in the current year; (3) a corporation,
partnership or similar business entity, not formed for the specific purpose of
acquiring the Securities, with total assets in excess of $5,000,000; and (4) any
entity in which all of the equity owners are accredited investors.

                  (g)      If the Investor is a corporation, partnership or
trust, the person executing this Agreement on behalf of such entity has all
right, power and authority to so execute and deliver this Agreement on behalf of
such entity and that the above representations, warranties, agreements,
acknowledgments and understandings shall be deemed to have been made on behalf
of the person or persons for whose benefit such Securities are being acquired.

                  (h)      The Company has afforded the Investor and its
advisors full and complete access to all information with respect to the Company
and its business and financial condition (to the extent that such information
was possessed by the Company or could be acquired by the Company without
unreasonable effort or expense) that the Investor and its advisors deemed
necessary in order to evaluate the merits and risks of an investment in the
Securities. The Investor further represents and warrants that its advisors have
received satisfactory and complete information concerning the business and
financial condition of the Company in response to all inquiries made by them in
respect thereof.

                  (i)      The offer to sell Securities was directly
communicated to the Investor, in such a manner that the Investor was able to ask
questions and receive answers concerning the terms of this transaction and that
at no time was the Investor presented with or solicited by any leaflet,
newspaper or magazine article, radio or television advertisement or any other
form of general advertising, or invited to any promotional meeting, otherwise
than in connection and concurrently with such communicated offer. No oral
representations have been made or oral information furnished to the Investor in
connection with the placement of Securities which were in any way inconsistent
with the Memorandum or its exhibits .

         4.2      Further Acknowledgments By Investor. The Investor represents
                  -----------------------------------
and warrants that the Investor has been advised that:

                  (a)      The Securities have not been registered under the
Securities Act, or under

                                       3

<PAGE>

the securities laws of any state and that the Securities must be held until the
Securities are registered under the Securities Act and applicable state
securities laws or an exemption from such registration is available.

                  (b)      No federal or state agency, including the U.S.
Securities and Exchange Commission (the "Commission"), or the securities
commission or authorities of any state or regulatory jurisdiction has approved
or disapproved the Securities, passed upon or endorsed the merits of the
Offering or the accuracy or adequacy of the Offering Documents, or made any
finding or determination as to the fairness of the Securities or an investment
in the Securities.

                  ( c)     The Securities that the Investor will be acquiring
may be considered "Restricted Securities" as that term is defined in Rule 144
promulgated under the Securities Act; that the exemption from registration under
Rule 144 will not be available in any event for at least two years from the date
of issuance, and even then will not be available unless (1) a public trading
market then exists for said Securities, (2) adequate information concerning the
Company is then available to the public, and (3) other terms and conditions of
Rule 144 are complied with.

                  (d)      Any and all certificates representing the Securities
shall bear a legend describing the aforementioned restrictions on the transfer
of such Securities which legend will not be removed until the Securities have
been registered under the Securities Act. The Securities are sold in accordance
with any of the provisions of Rule 144 or Rule l44A under the Securities Act, or
the Securities qualify for resale under Rule 144(k) promulgated under the
Securities Act.

                  ( e)     Investor understands that in the view of the
Commission the statutory basis for the exemption claimed for the transactions
contemplated by the Agreement would not be present if the offering of
Securities, although in technical compliance with Regulation D promulgated under
the Securities Act, is part of a plan or scheme to evade the registration
provisions of the Securities Act, and Investor confirms that its purchase is not
part of any such plan or scheme.

                  (f)      The Investor agrees that all certificates evidencing
the Securities shall bear a legend in substantially the following form, and by
which the Investor agrees to be bound, in addition to any legends required by
state securities laws:

                  THE SECURITIES REPRESENTED BY THIS CERTIFICATE HAVE
                  NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933 NOR
                  REGISTERED NOR QUALIF1ED UNDER ANY STATE SECURITIES LAWS. SUCH
                  SECURITIES MAY NOT BE OFFERED FOR SALE, SOLD, DELIVERED AFTER
                  SALE, TRANSFERRED, PLEDGED, OR HYPOTHECATED UNLESS QUALIFIED
                  AND REGISTERED UNDER APPLICABLE STATE AND FEDERAL SECURRRITIES
                  LAWS OR UNLESS, IN THE OPINION OF COUNSEL SATISFACTORY TO THE
                  COMPANY, SUCH QUALIFICATION AND REGISTRATION IS NOT REQUIRED.
                  ANY TRANSFER OF THE SECURITIES REPRESENTED BY THIS AGREEMENT
                  IS FURTHER SUBJECT TO OTHER RESTRICTIONS, TERMS AND CONDITIONS
                  WHICH ARE SET FORTH HEREIN.

                  (g)      The Company shall make a notation regarding the
restrictions on transfer of the Securities in its stock books, and the Company
shall not be required to transfer on its books any of such Securities that have
been sold or transferred in violation of any of the provisions of this Agreement
or to treat as the owner of such Securities any transferee to whom such
securities have been so transferred.

         4.3      Registration of Shares.
                  ----------------------

                  (a)      Filing of Registration Statement. The Company shall
                           --------------------------------
use its best efforts to file with the Commission, on or before the date ninety
(90) days following the final Closing ("Final Closing") or the sale of
Securities to any investors participating in this Offering or the Overseas
Offering, a registration statement under the Securities Act covering the resale
of the

                                       4

<PAGE>

Common Stock (including shares of common stock issued or issuable as a dividend
or other distribution with respect to, or in exchange for, or in replacement of
such Common Stock) (collectively, the "Registrable Securities") by the holders
thereof (the "Holders"). Notwithstanding the foregoing, the Company shall not be
obligated to take any action to effect any such registration pursuant to this
Section 4.3 in any particular jurisdiction in which the Company would be
required to execute a general consent to service of process in effecting such
registration, unless the Company is already subject to service in such
jurisdiction and except as may be required by the Securities Act.

                  (b)      Company Obligations Regarding Registration Statement.
                           ----------------------------------------------------

                           The Company shall:

                           (i)      Keep the registration statement with respect
to the Registrable Securities filed pursuant to Section 4.3(a) of this Agreement
("Registration Statement") effective for the period from the date of declaration
of effectiveness of such Registration Statement through the earlier of: (i) the
date 24 months from the Fina1 Closing, or (ii) the sale of all of the
Registrable Securities;

                           (ii)     Prepare and file with the Commission such
amendments and supplements to such Registration Statement and the prospectus
used in connection with such Registration Statement as may be necessary to
comply with the provisions of the Securities Act with respect to the disposition
of all securities covered by such Registration Statement during the period of
its effectiveness; and

                           (iii)    Furnish to the Holders such numbers of
copies of a prospectus, including a preliminary prospectus, in conformity with
the requirements of the Securities Act, and such other documents as they may
reasonably request in order to facilitate the disposition of Registrable
Securities owned by them.

                  (c)      Investor Cooperation and Indemnification. The
                           ----------------------------------------
Investor agrees to cooperate fully with the Company in the preparation and
filing of the Registration Statement. The Investor will provide at its own
expense and in writing to the Company all information and data with respect to
itself and to its plan of distribution as shall be required by the rules and
regulations of the Commission, to be included in any such Registration
Statement. The Investor also agrees to comply fully with reasonable procedures
established by the Company in connection with the registration. The Investor
further agrees to indemnify, defend, and hold harmless the Company, each of its
directors, each of its officers who has signed such Registration Statement, (or
any amendment or supplement thereof) and each person, if any, who controls the
Company, within the meaning of the Securities Act, against any costs, expenses
(including attorneys' fees), losses, damages or liabilities to which the
Company, or any such director, officer or controlling person of the Company may
become subject under the Securities Act or otherwise, insofar as said costs,
expenses, losses, damages or liabilities (or actions in respect thereof) arise
out of or are based upon any violation by a selling stockholder under this
Agreement or any reasonable procedures established by the Company in connection
with the registration, or untrue statement or alleged untrue statement of
material fact contained in the registration statement (or any amendment or
supplement thereof), or arising out of or are based upon the omission or the
alleged omission to state therein a material fact required to be stated therein
or necessary to make the statements therein not misleading; provided, however,
that such indemnity shall apply only to the extent that such untrue statement or
alleged untrue statement or omission or alleged omission was made in reliance
upon and in conformity with information furnished by the Investor for use in the
preparation thereof.

                  (d)      Company Indemnification. The Company hereby agrees to
                           -----------------------
indemnify, defend, and hold harmless the Investor, each of its directors and
officers and each person, if any, who controls the Investor within the meaning
of the Securities Act against any costs, expenses (including attorneys fees),
losses, damages or liabilities to which the Investor or any such director or
officer or controlling person may become subject under the Securities Act or
otherwise insofar as said costs, expenses, losses, damages or liabilities (or
actions in respect thereof), arise out of or are based upon, any untrue
statement or alleged untrue statement of material fact contained in the
registration statement, (or any amendment or supplement thereof) or from the
omission or the alleged omission therein of a material fact required to be
stated therein or necessary to make the statements therein not misleading;
provided, however, that such indemnity shall apply only to the extent that such
untrue statement or alleged untrue statement or omission or alleged omission was
made in reliance upon and in conformity with

                                       5

<PAGE>

information furnished by the Company or any officer, director or controlling
person of the Company (other than the Investor) for use in the preparation
thereof and that the Company shall be entitled to control the defense and any
settlement of any such matter

                                    ARTICLE 5

               Conditions to the Company's Obligations at Closing

         The obligations of the Company under Section 1.2 of this Agreement are
subject to the fulfillment on or before the Closing of each of the following
conditions as to the Investor:

         5.1      Representations and Warranties True on the Closing. The
                  --------------------------------------------------
representations and warranties of the Investor contained in Sections 3 and 4
shall be true on and as of the Closing with the same force and effect as if they
had been made at the Closing.

         5.2      Payment of Purchase Price. The Investor shall have delivered
                  -------------------------
to the Company, the total consideration for all of the shares of Series C
Preferred which the Investor is purchasing at the Closing.

                                    ARTICLE 6

                               Series C Preferred

         6.1      Registration and Transfer of Series C Preferred.
                  -----------------------------------------------

                  (1)      The Company (or any designated agent of the Company)
shall, at all times while any shares of Series C Preferred are outstanding, act
as the registrar of the Series C Preferred and shall cause to be kept at its
principal office in the City of Portland, Oregon, or in such other place or
places and by such other registrar or registrars, if any, as the Company may
designate, a register in which shall be entered the names and addresses of the
registered holders of Series C Preferred and of all transfers of Series C
Preferred. The name of the registered holder shall be noted on the certificates
representing the Series C Preferred by the Company or other registrar.

                  (2)      No transfer of shares of Series C Preferred shall be
valid unless made by the registered holder or his executors or administrators or
other legal representatives or his or their attorney duly appointed by an
instrument in writing in form and execution satisfactory to the Company, upon
compliance with the provisions of this Agreement, applicable law, and such other
requirements as the Company and/or other registrar may reasonably prescribe, and
unless such transfer shall have been duly entered on the appropriate register by
the Company or other registrar. The person in whose name a share of Series C
Preferred is registered shall be deemed to be the owner thereof.

         6.2      Series C Preferred. The Series C Preferred shall have such
                  ------------------
conversion, dividend, liquidation preferences, and voting rights as set forth in
the Certificate of Designations.

         6.3      Reservation of Shares. The Company agrees that, so long as any
                  ---------------------
share of Series C Preferred shall remain outstanding, the Company shall at all
times reserve and keep available, out of its authorized capital stock for the
purpose of issue upon conversion of the Series C Preferred, the full number of
shares of Common Stock then issuable upon conversion of the outstanding Series C
Preferred.

         6.4      Va1idity of Shares. The Company agrees that all shares of
                  ------------------
Common Stock which may be issued upon conversion of the Series C Preferred will,
upon issuance, be legally and validly issued, fully paid and nonassessable.

                                       6

<PAGE>

                                    ARTICLE 7

                                  Miscellaneous

         7 .1     Survival of Warranties. The warranties, representations and
                  ----------------------
covenants contained in or made pursuant to this Agreement shall survive the
execution and delivery of this Agreement and the Closing and shall in no way be
affected by any investigation of the subject matter thereof made by or on behalf
of the Company or the Investor, as the case may be .

         7 .2     Entire Agreement. This Agreement constitutes the entire
                  ----------------
agreement between the parties, and neither party shall be liable or bound to the
other party in any manner by any warranties, representations or covenants except
as specifically set forth herein or therein. The terms and conditions of this
Agreement shall inure to the benefit of and be binding upon the respective
successors and assigns of the parties. Nothing in this Agreement, express or
implied, is intended to confer upon any third party any rights, remedies,
obligations or liabilities under or by reason of this Agreement, except as
expressly provided in this Agreement.

         7.3      Governing Law. This Agreement shall be governed and construed
                  -------------
under the laws of the State of Oregon as applied to agreements among Oregon
residents entered into and to be performed entirely within Oregon.

         7.4      Titles and Subtitles. The titles and subtitles used in this
                  --------------------
Agreement are used for convenience only and are not to be considered in
construing or interpreting this Agreement.

         7.5      Notices. Any notice required or permitted under this Agreement
                  -------
shall be given in writing and shall be deemed effectively given upon personal
delivery or seven (7) business days after deposit in the international or U. S.
mail, postage prepaid, addressed to the Company at OXIS International, Inc.,
6040 North Cutter Circle, Suite 317, Portland, Oregon 97217, and to the Investor
at the address set forth on the signature page hereto, or at such other address
as a party may designate by ten (10) days' advance notice to the other party.

         7.6      Expenses. The Company shall pay all costs and expenses that it
                  --------
incurs with respect of the negotiation, execution, delivery and performance of
the Offering, and each Investor shall pay all costs and expenses that it incurs
with respect to the negotiation, execution, delivery and performance of this
Agreement.

         7.7      Amendments and Waivers. Any term of this Agreement may be
                  ----------------------
amended and the observance of any term of this Agreement may be waived (either
generally or in a particular instance and either retroactively or
prospectively), with the written consent of the Company and the holders of a
majority of the shares of Series C Preferred purchased in this U.S. Offering
then outstanding. Any amendment or waiver effected in accordance with this
Section shall be binding upon each holder of the Series C Preferred purchased
under this Agreement at the time outstanding (including the shares of Common
Stock issuable upon conversion of the Series C Preferred), each future holder of
such Series C Preferred and the Company.

         7.8      Rights of Investors. Each holder of the Series C Preferred
                  -------------------
shall have the absolute right to exercise or refrain from exercising any right
or rights that such holder may have by reason of this Agreement or applicable
law as a holder of Series C Preferred, including, without limitation, the right
to consent to the waiver of any obligation of the Company under this Agreement
and to enter into an agreement with the Company for the purpose of modifying
this Agreement or any agreement effecting any such modification, and such holder
shall not incur any liability to any other holder or holders of the securities
with respect to exercising or refraining from exercising any such right or
rights.

         7.9      Severability. If one or more provisions or this Agreement are
                  ------------
held to be unenforceable under applicable law, such provisions shall be excluded
from this Agreement, and the balance of this Agreement shall be interpreted as
if such provisions were so excluded and shall be enforceable in accordance with
its terms.

                                       7

<PAGE>

         7.10     Counteparts. This Agreement may be executed in two or more
                  -----------
counterparts, each of which shall be deemed an original, but all of which
together shall constitute one and the same instrument.

         7.11     Gender. Words importing the neuter gender shall include the
                  ------
masculine and feminine gender.

         7.12     Definitions. Terms used herein and defined in the Memorandum
                  -----------
shall have the same meanings herein as therein defined.

                                    ARTICLE 8

                                  Subscription

         8.1      Subscription Amount. The undersigned hereby subscribes for
                  -------------------
[number of shares of Series C Preferred as per attachment to this Subscription]
shares of Series C Preferred (total purchase price $___________) and tenders
herewith a certified check or bank draft in full payment for such subscription
or shall tender such other evidence of payment in full for the Securities as
shall be acceptable to the Company, including forgiveness of outstanding
indebtedness.

         8.2      Resale Compliance. The undersigned agrees to comply with the
                  -----------------
Securities Act and the rules and regulations promulgated thereunder, and any
other relevant securities legislation and policies governing the purchase,
holding and resale of the securities subscribed for (or those issuable upon
conversion thereof), including, without limitation, applicable state blue sky
laws.

                                       8

<PAGE>

The undersigned acknowledges that this subscription shall not be effective
unless accepted by the Company as indicated below.

CORPORATE OR OTHER ENTITY:               INDIVIDUAL INVESTOR(S):

_________________________________
(Printed Name of Entity)

By: *____________________________        *_________________________________
    -                                    -
(Signature)                              (Signature)

_________________________________         _________________________________
(Name Printed)                            (Name Printed)

Title:___________________________         ________________________________
                                                 (Street Address)
_________________________________
(Street Address)                          ________________________________
                                                (City, State, Zip)
_________________________________
(City, State, Zip)                        ________________________________
                                                (Telephone Number)
_________________________________
(Telephone Number)
Federal I.D. No. ________________

                                    FORM OF OWNERSHIP

                                    [  ] individual      [  ] community property

                                    [  ] joint tenants   [  ] tenants in commong

                                    [  ] other ___________________

                                    * Signed by all investors

ACCEPTED:

OXIS INTERNATIONAL, INC., a Delaware corporation

By: _**____________________________
     --
         Name:
         Title:

Dated: ________________________, 1996

** Signed by Company

                                       9

<PAGE>

                            OXIS INTERNATIONAL, INC.

                        SERIES C PREFERRED STOCK OFFERING

                            (1,774,080 Total Shares)

--------------------------------------------------------------------------------
                 Holder                           Purchase Price        Shares
                 ------                            ($1.30/sh)           ------
                                                   ----------
--------------------------------------------------------------------------------

--------------------------------------------------------------------------------
Marc Dumont                                           100,070           76,977
--------------------------------------------------------------------------------
Legong Investments N.V.                               200,000          153,846
--------------------------------------------------------------------------------
Rauch & Co.                                           260,000          200,000
--------------------------------------------------------------------------------
Megapolis B.V.                                         24,999           19,230
--------------------------------------------------------------------------------
Carlo Gillet                                           40,300           31,000
--------------------------------------------------------------------------------
D.N.B.                                                100,000           76,923
--------------------------------------------------------------------------------
Sharon L. Carpenter IRS                                49,999           38,461
--------------------------------------------------------------------------------
Deborah A. Y. Day IRA                                 100,000           76,923
--------------------------------------------------------------------------------
Syliva Morio IRA                                       49,999           38,461
--------------------------------------------------------------------------------
Maxine Y. Yakushijin IRA                              100,000           76,923
--------------------------------------------------------------------------------
Terrance Y. Yoshikawa IRA                             200,000          153,846
--------------------------------------------------------------------------------
America HealthCare Fund, LP                           100,100           77,000
--------------------------------------------------------------------------------
Alta-Berkeley L.P. II                                 259,145          199,342
--------------------------------------------------------------------------------
Finovelec S.A.                                        202,222          155,555
--------------------------------------------------------------------------------
BBL France                                             65,000           50,000
--------------------------------------------------------------------------------
EGGER & Co., c/o chase Manhatt                         13,000           10,000
--------------------------------------------------------------------------------
EGGER & Co., c/o chase Manhatt                         13,000           10,000
--------------------------------------------------------------------------------
EGGER & Co., c/o chase Manhatt                         13,000           10,000
--------------------------------------------------------------------------------
EGGER & Co., c/o chase Manhatt                         13,000           10,000
--------------------------------------------------------------------------------
EGGER & Co., c/o chase Manhatt                          6,500            5,000
--------------------------------------------------------------------------------
EGGER & Co., c/o chase Manhatt                          1,300            1,000
--------------------------------------------------------------------------------
EGGER & Co., c/o chase Manhatt                         13,000           10,000
--------------------------------------------------------------------------------
FINNO S.A.                                            177,895          136,842
--------------------------------------------------------------------------------
Sofinnova Capital F.C.P.R.                            122,266           94,051
--------------------------------------------------------------------------------
Sofinnova S.A.                                         81,510           62,700
--------------------------------------------------------------------------------

--------------------------------------------------------------------------------
                                    TOTAL          $2,306,305        1,774,080
--------------------------------------------------------------------------------

                                       10

<PAGE>

         THIS WARRANT MAY NOT BE SOLD, TRANSFERRED OR OTHERWISE DISPOSED OF
         EXCEPT AS SPECIFIED IN SECTION 11 HEREOF. NEITHER THE RIGHTS
         REPRESENTED BY THIS WARRANT NOR THE SHARES ISSUABLE UPON THE EXERCISE
         HEREOF (COLLECTIVELY, THE "SECURITIES") HAVE BEEN REGISTERED FOR OFFER
         OR SALE UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE "SECURITIES
         ACT"), OR APPLICABLE STATE LAW, AND MAY NOT BE OFFERED OR SOLD WITHIN
         THE UNITED STATES, OR TO OR FOR THE ACCOUNT OR BENEFIT OF, UNITED
         STATES PERSONS, UNTIL 40 DAYS AFTER THE LATER OF THE COMMENCEMENT OF
         THE OFFERING AND THE CLOSING DATE, NOR MAY THE WARRANT BE EXERCISED BY
         OR ON BEHALF OF ANY U.S. PERSON, EXCEPT IN EITHER CASE IN ACCORDANCE
         WITH REGULATIONS UNDER THE SECURITIES ACT. THE RESALE SAFE HARBOR OF
         REGULATION S DOES NOT PERMIT THE RESALE OF THE SECURITIES IN THE UNITED
         STATES OR TO A U.S. PERSON. OFFERS AND SALES MAY BE MADE IN THE UNITED
         STATES OR TO U.S. PERSONS ONLY PURSUANT TO AN EFFECTIVE REGISTRATION
         STATEMENT UNDER THE SECURITIES ACT OR AN APPLICABLE EXEMPTION FROM THE
         REGISTRATION REQUIREMENTS UNDER SUCH ACT. THE SECURITIES MAY NOT BE
         SOLD OR OFFERED FOR SALE IN WHOLE OR IN PART NOR THE WARRANT EXERCISED
         EXCEPT IN ACCORDANCE WITH THE PROVISIONS OF SECTON 2 AND SECTION 11
         HEREOF.

                            OXIS INTERNATIONAL, INC.

                        WARRANT TO PURCHASE COMMON STOCK

         OXIS International, Inc., a Delaware corporation (the "Company"),
hereby certifies that, for value received, _________________ ("Investor"), the
registered holder hereof, or its registered assigns, is entitled, subject to the
terms set forth below, to purchase from the Company upon surrender of this
Warrant, at any time or times on or after the date hereof but not after 5 :00 P
..M., Portland time, on the Expiration Date (as defined herein),
___________________ (_____) fully paid nonassessable shares (the "Warrant
Shares") of Common Stock (as defined herein) of the Company (as adjusted from
time to time as provided in this Warrant) at an initial purchase price of U.S.
$1.43 per share in lawful money of the United States.

         Section 1.        (a)      Definitions. The following words and terms
                                    -----------
as used in this Warrant shall have the following meanings:

                  "Common Stock" means (a) the Company's common stock and (b)
                   ------------
any capital stock into which such "Common Stock" shall have been changed or any
capital stock resulting from a reclassification of such "Common Stock."

                  "Convertible Securities" mean any securities issued by the
                   ----------------------
Company which are convertible into or exchangeable for, directly or indirectly,
shares of Common Stock.

                  "Expiration Date" means May 8, 2001.
                   ---------------

                  "Warrant Exercise Price" shall initially be U.S. $1.43 per
                   ----------------------
share and shall be adjusted and readjusted from time to time as provided in this
Warrant.

                           (b)      Other Definitional Provisions. (i) Except as
                                    -----------------------------
otherwise specified herein, all references herein (A) to any person other than
the Company, shall be deemed to include such person's successors and assigns,
(B) to the Company shall be deemed to include the Company's successors and (C)
to any applicable law defined or referred to herein, shall be deemed references
to such applicable law as the same may have been or may be amended or
supplemented from time to time.

                                       11

<PAGE>

                  (ii)     When used in this Warrant, the words "herein,"
"hereof," and "hereunder," and words of similar import, shall refer to this
Warrant as a whole and not to any provision of this Warrant, and the words
"Section," "Schedule," and "Exhibit" shall refer to Sections of, and Schedules
and Exhibits to, this Warrant unless otherwise specified.

                  (iii)    Whenever the context so requires the neuter gender
includes the masculine or feminine, and the singular number includes the plural,
and vice versa.

         Section 2.        Exercise of Warrant. (a) Subject to the terms and
                           -------------------
conditions hereof, this Warrant may be exercised, in whole or in part, at any
time during normal business hours on or after the opening of business on the
date hereof and prior to the close of business on the Expiration Date. The
rights represented by this Warrant may be exercised by the holder hereof then
registered on the books of the Company, in whole or from time to time in part
(except that this Warrant shall not be exercisable as to a fractional share) by
(i) delivery of a written notice, in the form of the Subscription Notice
attached as Exhibit A hereto, of such holder's election to exercise this
Warrant, which notice shall specify the number of Warrant Shares to be
purchased, (ii) payment to the Company of an amount equal to the Warrant
Exercise Price multiplied by the number of Warrant Shares as to which the
Warrant is being exercised (plus any applicable issue or transfer taxes) in cash
or by certified or official bank check, for the number of Warrant Shares as to
which this Warrant shall have been exercised, and (iii) the surrender of this
Warrant, properly endorsed, at the principal office of the Company in Portland,
Oregon (or at such other agency or office of the Company as the Company may
designate by notice to the holder hereof); provided, that if such Warrant Shares
are to be issued in any name other than that of the registered holder of this
Warrant, such issuance shall be deemed a transfer and the provisions of Section
11 shall be applicable. In addition, exercise of the Warrant is expressly
conditioned upon the delivery to the Company by the holder thereof of either:
(x) written certification that it is not a "U.S. person" (as defined in
Regulation S promulgated under the Securities Act of 1933, as amended (the
"Securities Act")) and that the Warrant is not being exercised on behalf of a
U.S. person; or (y) a written opinion of counsel to the effect that the Warrant
and the Warrant Shares have been registered under the Securities Act or are
exempt from registration thereunder. THE WARRANT MAY NOT BE EXERCISED WITHIN THE
UNITED STATES AND THE WARRANT SHARES MAY NOT BE DELIVERED WITHIN THE UNITED
STATES UPON EXERCISE OF THE WARRANT, OTHER THAN IN OFFERINGS DEEMED TO MEET THE
DEFINITION OF AN "OFFSHORE TRANSACTION" PURSUANT TO RULE 902 OF REGULATION S,
UNLESS REGISTERED UNDER THE SECURITIES ACT OR AN EXEMPTION FROM SUCH
REGISTRATION IS AVAILABLE. EXERCISE OF THE WARRANT IS FULLY SUBJECT TO ALL
PROCEDURES ESTABLISHED BY THE COMPANY IN CONNECTION WITH THE FOREGOING SENTENCE
AND THE COMPANY WILL NOT HONOR ANY EXERCISE IF THE REQUIREMENTS OF THE FOREGOING
SENTENCE AND RELATED PROCEDURES ESTABLISHED BY THE COMPANY ARE NOT FULFILLED. In
the event of any exercise of the rights represented by this Warrant in
compliance with this Section 2(a), a certificate or certificates for the Warrant
Shares so purchased, registered in the name of, or as directed by, the holder,
shall be delivered to, or as directed by such holder within a reasonable time,
not exceeding 15 days, after such rights shall have been so exercised.

                  (b)      Unless the rights represented by this Warrant shall
have expired or have been fully exercised, the Company shall issue a new Warrant
identical in all respects to the Warrant exercised except (x) it shall represent
rights to purchase the number of Warrant Shares purchasable immediately prior to
such exercise under the Warrant exercised, less the number of Warrant Shares
with respect to which such Warrant was exercised, and (y) the holder thereof
shall be deemed to have become the holder of record of such Warrant Shares
immediately prior to the close of business on the date on which the Warrant was
surrendered and payment of the amount due in respect of such exercise and any
applicable taxes was made, irrespective of the date of delivery of such share
certificate, except that, if the date of such surrender and payment is a date
when the stock transfer books of the Company are properly closed, such person
shall be deemed to have become the holder of such Warrant Shares at the opening
of business on the next succeeding date on which the stock transfer books are
open.

         Section 3.        Covenants as to Common Stock. The Company covenants
                           ----------------------------
and agrees that all Warrant Shares which may be issued upon the exercise of the
rights represented by this Warrant will, upon issuance, be validly issued, fully
paid and nonassessable. The Company further covenants and agrees that during the
period within which the rights represented by this Warrant may be exercised, the
Company will at all times have authorized

                                       12

<PAGE>

and reserved a sufficient number of shares of Common Stock to provide for the
exercise of the rights then represented by this Warrant and that the par value
of said shares will at all times be less than or equal to the applicable Warrant
Exercise Price.

         Section 4.        Adjustment of Warrant Exercise Price Upon Stock
                           -----------------------------------------------
Splits, Dividends, Distributions and Combinations: and Adjustment of Number of
------------------------------------------------------------------------------
Shares. (a) In case the Company shall at any time subdivide its outstanding
------
shares of Common Stock into a greater number of shares or issue a stock dividend
or make a distribution with respect to outstanding shares of Common Stock or
Convertible Securities payable in Common Stock or in Convertible Securities, the
Warrant Exercise Price in effect immediately prior to such subdivision or stock
dividend or distribution shall be proportionately reduced (treating for such
purpose any such shares of Convertible Securities outstanding or payable as
being the number of shares of Common Stock issuable upon their conversion) and
conversely, in case the outstanding shares of Common Stock of the Company shall
be combined into a smaller number of shares, the Warrant Exercise Price in
effect immediately prior to such combination shall be proportionately increased
in each case by multiplying the then effective Warrant Exercise Price by a
fraction, the numerator of which shall be the number of shares of Common Stock
outstanding immediately prior to such action and the denominator of which shall
be the number of shares of Common Stock outstanding immediately after such
action, and the product so obtained shall thereafter be the Warrant Exercise
Price.

                  (b)      Upon each adjustment of the Warrant Exercise Price as
provided above in this Section 4, the registered holder of this Warrant shall
thereafter be entitled to purchase, at the Warrant Exercise Price resulting from
such adjustment, the number of shares obtained by multiplying the Warrant
Exercise Price in effect immediately prior to such adjustment by the number of
shares purchasable pursuant hereto immediately prior to such adjustment and
dividing the product thereof by the Warrant Exercise Price after such
adjustment.

         Section 5.        Notice of Adjustment of Warrant Exercise Price. Upon
                           ----------------------------------------------
any adjustment of the Warrant Exercise Price, then the Company shall give notice
thereof to the registered holder of this Warrant, which notice shall state the
Warrant Exercise Price in effect after such adjustment and the increase, or
decrease, if any, in the number of shares purchasable at the Warrant Exercise
Price upon the exercise of this Warrant, setting forth in reasonable detail the
method of calculation and the facts upon which such calculation is based.

         Section 6.        Computation of Adjustments. Upon each computation of
                           --------------------------
an adjustment in the Warrant Exercise Price and the number of shares which may
be subscribed for and purchased upon exercise of this Warrant, the Warrant
Exercise Price shall be computed to the nearest cent (i.e., fractions of .5 of a
cent, or greater, shall be rounded to the next highest cent) and the number of
shares which may be subscribed for and purchased upon exercise of this Warrant
shall be calculated to the nearest whole share (i.e., fractions of less than one
half of a share shall be disregarded and fractions of one half of a share, or
greater, shall be treated as being a whole share).

         Section 7.        No Change in Warrant Terms on Adjustment.
                           ----------------------------------------
Irrespective of any adjustment in the Warrant Exercise Price or the number of
shares of Common Stock issuable upon exercise hereof, this Warrant, whether
theretofore or thereafter issued or reissued, may continue to express the same
price and number of shares as are stated herein and the Warrant Exercise Price
and such number of shares specified herein shall be deemed to have been so
adjusted.

         Section 8.        Taxes. The Company shall not be required to pay any
                           -----
tax or taxes attributable to the initial issuance of the Warrant Shares or any
transfer involved in the issue or delivery of any certificates for Warrant
Shares of Common Stock in a name other than that of the registered holder hereof
or upon any transfer of this Warrant.

         Section 9.        Warrant Holder Not Deemed a Shareholder. No holder,
                           ---------------------------------------
as such, of this Warrant shall be entitled to vote or receive dividends or be
deemed the holder of shares of the Company for any purpose, nor shall anything
contained in this Warrant be construed to confer upon the holder hereof, as
such, any of the rights of a shareholder of the Company or any right to vote,
give or withhold consent to any corporate action (whether any reorganization,
issue of stock, reclassification of stock, consolidation, merger, conveyance or
otherwise), receive

                                       13

<PAGE>

notice of meetings, receive dividends or subscription rights, or otherwise,
prior to the issuance to the holder of this Warrant of the Warrant Shares which
he is then entitled to receive upon the due exercise of this Warrant.

         Section 10.       No Limitation on Corporate Action. No provisions of
                           ---------------------------------
this Warrant and no right or option granted or conferred hereunder shall in any
way limit, affect or abridge the exercise by the Company of any of its corporate
rights or powers to recapitalize, amend its Certificate of Incorporation,
reorganize, consolidate or merge with or into another corporation, or to
transfer all or any part of its property or assets, or the exercise of any other
of its corporate rights and powers.

         Section 11.       Transfer: Opinions of Counsel: Restrictive Legends.
                           --------------------------------------------------

                  (a)      Prior to any sale, transfer or other disposition of
this Warrant or the Warrant Shares, the holder thereof will give ten (10) days'
notice to the Company of such holder's intention to effect such transfer. Each
such notice shall describe the manner and circumstances of the proposed transfer
and, if such transfer is not registered under the Securities Act (below
defined), shall be accompanied by an opinion, addressed to the Company and
reasonably satisfactory in form and substance to it, of counsel (reasonably
satisfactory to the Company) for such holder, stating whether, in the opinion of
such counsel, such transfer will be a transaction exempt from registration under
the Securities Act.

                  (b)      If such sale, transfer or other disposition may in
the opinion of such counsel be effected without registration under the
Securities Act, such holder shall thereupon be entitled to the terms of the
notice delivered by such holder to the Company. If in the opinion of such
counsel such transfer may not be effected without registration under the
Securities Act, such holder shall not be entitled to so transfer this Warrant,
or the Warrant Shares unless the Company shall have filed a registration
statement relating to such proposed transfer and such registration statement has
become effective under the Securities Act.

                  (c)      Subject to the provisions of this Section 11, the
holder may at any time transfer this Warrant or the Warrant Shares to an
affiliate of the holder.

                  (d)      The terms of any registration rights agreement
entered into by and between the Company and the holder hereof, to the extent
applicable, shall be binding upon and inure to the benefit of any transferee of
this Warrant (or unexercised portion hereof) or Warrant Shares issued upon the
exercise of this Warrant, and shall cease to be binding upon or benefit the
transferor.

                  (e)      Any Warrant Shares issued pursuant to the exercise of
this Warrant may bear one or more of the legends in similar form to the legend
set forth on this Warrant.

         Section 12.       Exchange of Warrant. This Warrant is exchangeable
                           -------------------
upon the surrender hereof by the holder hereof at such office or agency of the
Company, for new Warrants of like tenor representing in the aggregate the right
to subscribe for and purchase the number of shares which may be subscribed for
and purchased hereunder from time to time after giving effect to all the
provisions hereof, each of such new Warrants to represent the right to subscribe
for and purchase such number of shares as shall be designated by said holder
hereof at the time of such surrender .

         Section 13.       Lost, Stolen. Mutilated or Destroyed Warrant. If this
                           --------------------------------------------
Warrant is lost, stolen, mutilated or destroyed, the Company shall, on such
terms as to indemnity or otherwise as it may in its discretion impose (which
shall, in the case of a mutilated Warrant, include the surrender thereof), issue
a new Warrant of like denomination and tenor as the Warrant so lost, stolen,
mutilated or destroyed. Any such new Warrant shall constitute an original
contractual obligation of the Company, whether or not the allegedly lost,
stolen, mutilated or destroyed Warrant shall be at any time enforceable by
anyone.

         Section 14.       Representation of Holder. The holder of this Warrant,
                           ------------------------
by the acceptance hereof, represents that it is acquiring this Warrant for its
own account for investment and not with a view to, or sale in connection with,
any distribution hereof or of any of the shares of Common Stock or other
securities issuable upon the exercise thereof, nor with any present intention of
distributing any of the same.

                                       14

<PAGE>

         Section 15.       Notice. All notices and other communications under
                           ------
this Warrant shall (a) be in writing (which shall include communications by
telecopy), (b) be (i) sent by registered or certified mail, postage prepaid,
return receipt requested, by telecopier, or (ii) delivered by hand, ( c ) be
given at the following respective addresses and telecopier numbers and to the
attention of the following persons:

                  (i)      if to the Company, to it at:

                                    OXIS International, Inc.
                                    Corporate Headquarters
                                    6040 N. Cutter Circle, Suite 317
                                    Portland, Oregon 97217-3935
                                    Attention: Ray R. Rogers, Chairman
                                    Telephone: (503) 283-3911
                                    Telecopier: (503) 283-4058

                           with a copy to:

                                    Jackson, Tufts, Cole & Black
                                    60 South Market Street
                                    San Jose, CA 95113
                                    Attention: Richard Scudellari, Esq.
                                    Telephone: (408) 998-1952
                                    Telecopier: (408) 998-4889

                  (ii)     if to Investor, to it at the address set forth below
Investor's signature on the signature page hereof.

or at such other address or telecopier number or to the attention of such other
person as the party to whom such information pertains may hereafter specify for
the purpose in a notice to the other specifically captioned "Notice of Change of
Address", and (d) be effective or deemed delivered or furnished (i) if given by
mail, on the fifth Business Day after such communication is deposited in the
mail, addressed as above provided, (ii) if given by telecopier, when such
communication is transmitted to the appropriate number determined as above
provided in this Section and the appropriate answer back is received or receipt
is otherwise acknowledged, and (iii) if given by hand delivery, when left at the
address of the addressee addressed as above provided, except that notices of a
change of address, telecopier or telephone number, shall not be deemed
furnished, until received.

         Section 16.       Miscellaneous. This Warrant and any term hereof may
                           -------------
be changed, waived, discharged, or terminated only by an instrument in writing
signed by the party or holder hereof against which enforcement of such change,
waiver, discharge or termination is sought. The headings in this Warrant are for
purposes of reference only and shall not limit or otherwise affect the meaning
hereof. This Warrant shall be governed by and interpreted under the laws of the
State of Oregon.

         Section 17.       Date. The date of this Warrant is May 9, 1996. This
                           ----
Warrant, in all events, shall be wholly void and of no effect after the close of
business on the Expiration Date, except that notwithstanding any other
provisions hereof, the provisions of Section 11 shall continue in full force and
effect after such date as to any Warrant Shares or other securities issued upon
the exercise of this Warrant.

                                      OXIS INTERNATIONAL, INC.
                                      By: ______________________________
                                      Name: ____________________________
                                      Title: ___________________________

ACCEPTED:
--------

_____________________________

BY:__________________________
Name:________________________
Title:_______________________
Address:_____________________

                                       15

<PAGE>

                              EXHIBIT A TO WARRANT
                              --------------------

                                SUBSCRIPTION FORM

TO BE EXECUTED BY THE REGISTERED HOLDER IF SUCH REGISTERED HOLDER DESIRES TO
EXERCISE THIS WARRANT

OXIS INTERNATIONAL, INC.

         The undersigned hereby exercises the right to purchase Warrant Shares
covered by this Warrant according to the conditions thereof and herewith makes
payment of U.S. $_________, the aggregate Warrant Exercise Price of such Warrant
Shares in full.

         The undersigned further certifies that either: (i) it is not a "U.S.
person" (as defined in Regulation S promulgated under the Securities Act of
1933, as amended (the "Securities Act")) and that the Warrant is not being
exercised on behalf of a U.S. person; or (ii) the undersigned is providing to
the Company herewith a written opinion of counsel to the effect that the Warrant
and the Warrant Shares have been registered under the Securities Act or are
exempt from registration thereunder.

                                      INVESTOR:

                                      By:______________________________________
                                      Name: ___________________________________
                                      Title:___________________________________
                                      Address:_________________________________
                                      _________________________________________
                                      _________________________________________

                                      Number of Warrant Shares Being Purchased:
                                      _________________________________________

Dated:____________, 199___.

                                       16<PAGE>

                                                                   EXHIBIT 10.29

May 21, 2001

Kal Raman

Dear Kal:

     On behalf of drugstore.com, inc. (the "Company"), we are pleased to confirm
your appointment to the position of President and Chief Executive Officer
effective April 26, 2001. You will report directly to the Company's Board of
Directors.

     You will receive an annual salary of $350,000, along with the Company's
standard employee benefits. Your salary will be paid in accordance with the
Company's standard payroll policies. You will be eligible to receive a bonus of
up to $350,000 annually, based upon the Company's performance. The exact bonus
formula will be determined by mutual agreement with you. In addition, you will
receive a $75,000 signing bonus upon your acceptance of this letter. You will
also receive a $25,000 bonus after one year, assuming your continued employment
with the Company. Your compensation package will be reviewed annually by the
Company's Board of Directors.

     You will be granted an option (the "Option") to purchase 1,000,000 shares
of drugstore.com, inc. common stock. The exercise price will be equal to the
fair market value of such shares on April 26, 2001, which was $1.53 per share.
The options will vest in equal monthly installments over a three-year period.
Vesting will depend upon your continued employment with the Company. The Option
will be subject to the terms of the Company's 1998 Stock Option Plan and the
related Stock Option Agreement between you and drugstore.com.

     All of us at the Company are very excited about your promotion and look
forward to continuing a beneficial and rewarding relationship. Nevertheless,
your employment at drugstore.com may be terminated by you or drugstore.com at
any time for any reason with or without cause or notice.

     This letter supercedes and replaces the Employment Offer Letter between you
and the Company dated July 28, 1998. The terms of this offer letter may only be
changed by written agreement, although the Company may from time to time, in its
sole discretion, adjust the salaries and benefits paid to you and its other
employees.

     Should you have any questions with regard to any of the items indicated
above, please contact Alesia Pinney. Kindly indicate your consent to the terms
contained in this offer letter by signing and returning a copy to us by May 25,
2001.

Sincerely,

drugstore.com, inc.

/s/ Peter Neupert
--------------------------
Peter Neupert
Chairman

Agreed to and accepted:

/s/ Kal Raman                                   Date:  May __, 2001
--------------------------
Kal Raman

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00037-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00037-of-00352.parquet"}]]